Ratio 125%: reformulate [RSABE / ABEL]

posted by Ohlbe – France, 2012-05-09 18:40 (4753 d 20:36 ago) – Posting: # 8547
Views: 7,712

Dear drsinghs,

❝ Ok if my study is for EMA and observed ratio for AUCt is 125% with 90% CI 110 lower and 140 upper, Can I expect 90% CI to be within 80.00-125.00% in replicate design study.


If your observed T/R ratio is 125 %, your chances to get a 90 % CI within 80.00 - 125.00 % in the next study, even with a replicate design, are close to nil.

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
69 visitors (0 registered, 69 guests [including 39 identified bots]).
Forum time: 15:17 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5